UPCYTE TECHNOLOGIES
Upcyte Technologies is a life science company specialized in the controlled, and standardization of quasi (human) primary cell products. With our proprietary upcyte® technology, we are able to expand human primary cells thereby generating proliferating assay-ready cells from various human healthy or diseased tissues. The well characterized cell strains retain primary-like metabolic and physiological features as well as the typical cell-type specific morphology. upcyte® products make human primary cells accessible for meaningful standardized and cost-effective cell based assays to be used in a wide range of applications in life science research and pharmaceutical development.
UPCYTE TECHNOLOGIES
Social Links:
Industry:
Biotechnology Life Science
Founded:
2015-01-01
Address:
Hamburg, Hamburg, Germany
Country:
Germany
Website Url:
http://www.upcyte.com
Total Employee:
1+
Status:
Active
Contact:
+49 (0) 176/22949908
Email Addresses:
[email protected]
Technology used in webpage:
OVH HCaptcha
Similar Organizations
artus
artus is a biotechnology company specialized in the development, production and sale of diagnostic kits.
Sanofi Germany
Sanofi is a life sciences company specialising in the development, manufacture, and marketing of innovative therapeutic solutions.
Investors List
IFB Innovationsstarter
IFB Innovationsstarter investment in Seed Round - Upcyte Technologies
Official Site Inspections
http://www.upcyte.com Semrush global rank: 15.64 M Semrush visits lastest month: 1
- Host name: clinide2.peel.fr
- IP address: 145.239.121.131
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Upcyte Technologies"
Upcyte
Osterfeldstrasse 12-14 22529 Hamburg - Germany Tel.: +49 221 9498320 Email: [email protected] >> Worldwide offices and Distributors >>See details»
Upcyte Technologies - Crunchbase Company Profile
Upcyte Technologies is a life science company specialized in the controlled, and standardization of quasi (human) primary cell products. With our proprietary …See details»
upcyte technologies (Upcyte Technologies GmbH) - Startbase
Jobs at upcyte technologies: Other Startups nearby. Beyer & Söhne. Startup 2014 Hamburg. Beyer & Söhne. Produces and sells anti-aging skincare via online shop. Immunservice. …See details»
Upcyte Technologies - Funding, Financials, Valuation & Investors
Upcyte Technologies is a life science company specialized in the controlled, and standardization of quasi (human) primary cell products. New. Resources. ... How much funding has this …See details»
upcyte technologies GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for upcyte technologies GmbH of Hamburg, Hamburg. Get the latest business insights from Dun & …See details»
Upcyte Technologies | VentureRadar
Upcyte technologies is a life science company specialized in the controlled, scalable propagation and standardization of human primary cell products. ... Find out more about Upcyte …See details»
Upcyte Technologies Gmbh - Drug pipelines, Patents, Clinical trials ...
Explore Upcyte Technologies Gmbh with its drug pipeline, therapeutic area, technology platform, 9 literature.See details»
Company profile upcyte
By using our upcyte® protocol non-dividing primary cells can be pushed back into proliferation without altering their most relevant tissue-specific characteristics. We provide assay-ready …See details»
Upcyte Technologies - Regenerative Medicine Now
Upcyte technologies is a life science company specialized in the controlled, scalable propagation and standardization of human primary cell products. The company is currently located in …See details»
Upcyte Technologies - Craft
Upcyte Technologies is a life science company specialized in the controlled, scalable propagation and standardization of quasi (human) primary cell products. Its technology is able to expand …See details»
upcyte technologies - Products, Competitors, Financials, …
Upcyte Technologies focuses on providing expanded primary cells for research and development. The company utilizes technology for the controlled and scalable propagation of human primary …See details»
upcyte technologies Overview | SignalHire Company Profile
Upcyte technologies is a private company. The company currently specializes in the Biotechnology area. The upcyte technologies annual revenue is estimated at < 1M ...See details»
Upcyte technology
Therefore, upcyte® cells are available in sufficient quantities with a consistent quality that can be used for research, screening and drug development. We can expand up to 4000 vials per cell …See details»
upcyte technologies (Upcyte Technologies GmbH) - Startbase
Juristische Person: Upcyte Technologies GmbH Bundesland: Hamburg Übersicht Unternehmen Finanzierung Produkt Team Nachrichten Ist das dein Unternehmen? Profil ist noch nicht …See details»
upcyte technologies - Overview, News & Similar companies
Upcyte Technologies is a life science company specialized in the controlled, and standardization of quasi (human) primary cell products. With our proprietary upcyte® technology, we are able …See details»
How to order ? upcyte
Osterfeldstrasse 12-14 22529 Hamburg - Germany Tel.: +49 221 9498320 Email: [email protected] >> Worldwide offices and Distributors >>See details»
BioIVT Appointed Worldwide Distributor of upcyte Products for …
WESTBURY, NY — January 27, 2020 — BioIVT, a leading provider of research models and services for drug and diagnostic development, today (Jan. 27) announced that it has been …See details»
Upcyte® hepatocytes
Upcyte® hepatocytes are provided in 2 ml cryo-vials with a minimum of 5×106 frozen cells per vial and are ready-to-use. Our cryopreserved upcyte® hepatocytes are at a later state in …See details»
Exyte announces Katrien Verlinden as new President of its Global ...
6 days ago Most recently, Verlinden served as President and CEO of Saipem America Inc., and Country Manager for Saipem in North America. She brings more than 25 years of international …See details»
Upcyte cells
Novel upcyte® technology uses a viral gene transfer system to cause primary cells to proliferate, allowing up to 3,000 vials to be made from one initial vial. The expanded cells show consistent …See details»